The partnership aims to foster deep-science innovations in digitally enabled medical technologies that are affordable, scalable, and clinically impactful
Healthium Medtech and the Centre for Cellular and Molecular Platforms (C-CAMP) launched the first cohort of the C-CAMP Healthium Innovations Program for Surgical Interventions and Medical Technologies in Bengaluru.
The programme is a part of the CSR initiative of Healthium Medtech. The partnership aims to foster deep-science innovations in digitally enabled medical technologies that are affordable, scalable, and clinically impactful. In its first year, the initiative focuses on surgical interventions, an area undergoing rapid modernisation globally but still marked by limited access and affordability across large parts of India.
Despite the increasing adoption of advanced surgical technologies in metropolitan hospitals, smaller healthcare systems in Tier II and Tier III cities often remain underserved. The high cost of imported solutions, along with infrastructure and training gaps, has made it difficult to scale access to modern surgical care. This program was created to address these challenges by nurturing India-led, frugal, and scalable innovations that are tailored for local needs without compromising on quality or outcomes.
The initiative brings together two organisations with complementary strengths. Healthium Medtech brings deep expertise in surgical and post-surgical technologies, supported by a diverse product portfolio and robust manufacturing capabilities. The company operates six facilities with global certifications and holds over 85 patents across India, the US, and Europe. C-CAMP, an initiative supported by the Department of Biotechnology, Government of India, has built one of the country’s leading life sciences innovation ecosystems, having supported over 550 deep-tech start-ups across domains and connected with 3000 more.
Together, the collaboration combines clinical insight, market access and ecosystem support to help early-stage ventures overcome critical barriers from research to commercialisation.
The launch event featured inaugural remarks, a showcase by the selected start-ups, and a campus tour. The inaugural cohort includes start-ups like BrainSight AI, Nesa Medtech, Cartosense, Shira Medtech, Samaritan AI, Quixotix, Roots to Cusps, and Healyantra. These ventures are working across domains such as neurology, urology, AI-enabled surgical planning, and diagnostic imaging.
Anish Bafna, CEO and Managing Director, Healthium Medtech, said, “At Healthium, our vision has always been to make quality healthcare more accessible. By collaborating with C-CAMP, we are creating a strong platform for innovators who are tackling some of the most pressing surgical and medical challenges in India. The first cohort reflects the breadth of ideas and talent that can truly shape the future of healthcare.”
Dr Taslimarif Saiyed, CEO and Director, C-CAMP, said, “India’s medtech ecosystem is at a critical juncture where innovation must be paired with affordability and scalability. Through this program with Healthium, we are enabling start-ups not only with resources and mentorship, but also with an ecosystem that can help them transform their technologies into solutions that impact lives at scale.”
Over the next nine months, the selected start-ups will receive structured mentorship and incubation support at C-CAMP and access to clinical and industry expertise to help advance their technologies toward market readiness and adoption. The launch of this program comes at a time when India’s medtech sector is gaining momentum, supported by policy initiatives, rising domestic demand, and growing investor interest.
